Interleukin-6 Receptor Antagonist
- Name
- Interleukin-6 Receptor Antagonist
- Accession Number
- DBCAT003466 (DBCAT004312)
- Description
Not Available
- Drugs
Drug Drug Description Tocilizumab An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). Sarilumab A monoclonal antibody used to treat moderate to severe rheumatoid arthritis who have responded poorly or are intolerant of other DMARDs. Satralizumab A subcutaneously injected anti-IL-6 receptor monoclonal antibody for the treatment of neuromyelitis optica spectrum disorder (NMOSD). - Drugs & Drug Targets